Emerging endovascular therapies for symptomatic intracranial atherosclerotic disease.

  title={Emerging endovascular therapies for symptomatic intracranial atherosclerotic disease.},
  author={David J. Fiorella and Henry H. Woo},
  volume={38 8},
Over the past 2 decades there has been an exponential growth in the scope of disease processes amenable to neuroendovascular treatment. The number and sophistication of the available devices and correspondingly the number of patients undergoing treatment has expanded accordingly. The development and implementation of these new procedures has in some cases outpaced our ability to carefully assess their merits. In comparison to peripheral and coronary vascular disease, neurovascular lesions are… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 14 extracted citations

Pharos neurovascular intracranial stent: elective use for a symptomatic stenosis refractory to medical therapy.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions • 2009
View 4 Excerpts
Highly Influenced


Publications referenced by this paper.
Showing 1-10 of 50 references

Early and late coronary stent thrombosis of sirolimus eluting and paclitaxel eluting stents in routine clinical practice: Data from a large two-institutional cohort study

J Daemen, K Tsuchida, +11 authors PW. Serruys
Lancet • 2007

on behalf of the Multicenter Neuroendovascular Research Collaboration.) US Wingspan Registry: Results at 1 year

FC Albuquerque
Presented at the 2007 International Stroke Conference, • 2007

Similar Papers

Loading similar papers…